180 Life Sciences shares fall 5.78% premarket after announcing a $500 million stock offering.

180 Life Sciences Corp. fell 5.78% in premarket trading, with the company's shares dropping after announcing a $500 million stock offering. The company is focused on developing new technologies across multiple sectors, including the iGaming sector through its iGaming Technology Platform, and continues to evaluate monetization strategies for its biotechnology assets.